Product Reports Resources Pricing Login Book a demo

Nuoyimeier (Suzhou) Medical Technology

Health Tech & Medtech · China · Founded 2017

A company developing implantable consumables MoreLess

Nuoyimeier (Suzhou) Medical Technology, also known as Neo Modulus, was established in March 2017 through a collaboration of Chinese and German scientists. The company operates in the field of regenerative medicine, focusing on the research, development, and production of implantable medical devices. Its core mission is to facilitate complex tissue regeneration and organ reconstruction.

The firm specializes in creating nanoscale scaffolds for tissue engineering that are designed to guide the targeted growth and differentiation of cells. These scaffolds are developed using advanced techniques like biomimetic additive manufacturing, electrospinning, and 3D printing to create precise pore structures that provide mechanical support and a suitable environment for cell growth. The product line includes membranes, artificial bone, adhesives, and microspheres, which have applications in various clinical fields such as oral medicine, ophthalmology, ENT, and sports medicine. The technology leverages principles of light, heat, and radiation to build these structures, ensuring characteristics like bioactivity, degradability, and histocompatibility.

Neo Modulus serves the medical sector, providing its regenerative products to healthcare professionals and institutions. The business model appears to be centered on the development, manufacturing, and commercialization of these high-tech medical consumables. The company has established multiple R&D and production bases in Suzhou, Weifang, Taicang, and Shanghai, in addition to an overseas laboratory in Freiburg, Germany. A significant milestone was achieved in November 2023 when the company obtained NMPA approval for a Class III registration certificate, and it also launched the first phase of an R&D and production base in Shandong.

Keywords: regenerative medicine, implantable medical devices, tissue engineering, organ reconstruction, nanoscale scaffolds, biomimetic additive manufacturing, 3D bioprinting, electrospinning, guided tissue regeneration, medical consumables, artificial bone, surgical adhesives, ophthalmology medical devices, sports medicine technology, oral regenerative medicine

Company overview

Nuoyimeier (Suzhou) Medical Technology company information

The essential company record, classifications and operating signals in one place.

Status
Operational
Founded
2017
Headquarters
China
Employees
Open positions
None listed
Dealroom signal
19.3
client focusb2btechnologyDeep Techsub industryMedical DevicesindustryHealthsectormedical implantssectorSurgerysectorHard TechsectorDT and LSsectorscience-based

Valuation & funding

Nuoyimeier (Suzhou) Medical Technology funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES BEquity / VC Mar 2023 $28M $110M Junmao Capital · CDH Investments · 10Fund · SND Ventures Group
Showing 1 recorded eventsUnlock the complete deal history →

Comparisons

Nuoyimeier (Suzhou) Medical Technology compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Nuoyimeier (Suzhou) Medical Technology's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators Hidden — book a demo quality score
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

6 investors on Nuoyimeier (Suzhou) Medical Technology's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Series A 6 investors entered at this stage
Junmao Capital
CDH Investments
10Fund
SND Ventures Group
Hyfinity Investments
Clivia Capital

Global footprint

Where Nuoyimeier (Suzhou) Medical Technology has talent and traffic

Workforce by country
🇨🇳 China HQ
Book a demo for the full country breakdown

In the news

Latest news about Nuoyimeier (Suzhou) Medical Technology

Recent press, funding announcements, and product moves mentioning Nuoyimeier (Suzhou) Medical Technology — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Nuoyimeier (Suzhou) Medical Technology

An AI-synthesized read of the highest-engagement posts about Nuoyimeier (Suzhou) Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Nuoyimeier (Suzhou) Medical Technology’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.